Curia - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Curia M&A Summary

Curia has acquired 14 companies of its own, including 4 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 1 asset.

Curia’s largest acquisition to date was in 2016, when it acquired Archimica for $358M. Curia has acquired in 5 different US states, and 4 countries. The Company’s most targeted sectors include life science (82%) and healthcare services (10%).

Curia Ownership

Who owns Curia?

Curia is owned by Bourne Partners Strategic Capital, GTCR, HarbourVest Partners and The Carlyle Group. It was acquired on June 6, 2017.

Is Curia PE-backed?

Yes. Curia is owned by private equity investors Bourne Partners Strategic Capital, GTCR, HarbourVest Partners and The Carlyle Group.

Curia Business Overview

Where is Curia headquartered?

Curia is headquartered in Albany, New York.

What is Curia’s revenue?

Curia disclosed revenue of 402M USD for 2015 and 276M USD for 2014.

How many employees does Curia have?

Curia has 2,220 employees.

What sector is Curia in?

Curia is a life science company.

When was Curia founded?

Curia was founded in 1991.

M&A Summary

  • M&A Total Activity12
    • M&A Buy Activity11
    • M&A Sell Activity1
  • Total Sectors Invested 3
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 11
  • M&A Advisors 7

Curia

Curia Global, Inc.

26 Corporate Circle,
Albany, New York 12203
United States,
(518) 512-2000
www.curiaglobal.com

Curia is a provider of global contract research and manufacturing services to the pharmaceutical and biotechnology industries. The company's services include drug discovery, such as medicinal chemistry, discovery biology, and in vitro ADME, development, such as pre-formulation, formulation and validation and manufacturing, such as CGMP API manufacturing. Curia was founded in 1991 and is based in Albany, New York.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.6/yr) # 8 - 2 - - 1 11
vol $816M $816M
Sell (0.0/yr) # 1 - - - - - 1
  12

Most Recent M&A

Company Date Value Type
Whitehouse Analytical Laboratories 2024-03-14 - Divestiture
Lebanon, New Jersey · www.whitehouselabs.com
LakePharma, Inc. 2021-07-14 - Add-on Acquisition
San Carlos, California · www.lakepharma.com
Integrity Bio, Inc. 2021-07-13 - Divestiture
Camarillo, California · www.integritybio.com
Archimica S.p.A. 2019-08-01 - Divestiture
Lodi, Italy · www.archimica.com
Archimica S.p.A. 2016-05-05 358M USD Add-on Acquisition
Lodi, Italy · www.archimica.com
Whitehouse Laboratories 2015-12-15 54M USD Add-on Acquisition
Lebanon, New Jersey · www.whitehouselabs.com
Gadea Grupo Farmacéutico SL (Gadea Pharmaceutical Group) 2015-07-16 174M USD Add-on Acquisition
Valladolid, Spain · www.gadea.com
Aptuit - Aseptic Clinical Manufacturing 2015-01-09 60M USD Divestiture
Glasgow, United Kingdom
OSO BioPharmaceuticals Manufacturing LLC 2014-06-02 110M USD Add-on Acquisition
Albuquerque, New Mexico · www.osobio.com
Cedarburg Pharmaceuticals, Inc. 2014-04-04 41M USD Add-on Acquisition
Grafton, Wisconsin · www.cedarburghauser.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (82%) 706M (87%) 1 (100%) -
Healthcare Services 1 (9%) - - -
Medical Products 1 (9%) 110M (13%) - -
Total 11 $816M 1 -

By Geo

State/Country Buy Value Sell Value
United States 7 205M - -
  New Jersey 2 54M - -
  California 2 - - -
  Wisconsin 1 41M - -
  New Mexico 1 110M - -
  Massachusetts 1 - - -
Italy 1 358M 1 -
United Kingdom 2 79M - -
Spain 1 174M - -
Domestic 7 (64%) 205M (25%) - -
Cross-border 4 (36%) 611M (75%) 1 (100%) -
Total 11 $816M 1 -

Top M&A Advisors

Financial Deals
Nomura Investment Bank
1
RBC Capital Markets
1
BroadOak Capital Partners
1
Legal Deals
Goodwin Procter
2
Nelson Mullins Riley & Scarborough
1
Gomez-Acebo & Pombo Abogados
1

Deal Values

buy # Total
$100M to $1B 3 $642M
< $100M 4 $174M
TOTAL $816M
Largest Archimica S.p.A.
$358M (2016-05-05)

M&A Connections

Deals
Acquired from
Investor(s)
36%
4 (36%)
Strategic(s)
27%
3 (27%)
Divested to
Investor(s)
100%
1 (100%)

 Subscribe to unlock this and 207,692
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.